Protein biomarker of cell proliferation determines survival to discharge in cases of equine large colon volvulus.
- Journal Article
- Adult Horses
- Biomarkers
- Cell Proliferation
- Clinical Pathology
- Clinical Study
- Colic
- Diagnosis
- Disease Diagnosis
- Disease Treatment
- Equine Diseases
- Equine Health
- Hospitalization
- Immunohistochemistry
- Intestinal Pathology
- Intestinal Surgery
- Mortality
- Post-Operative Period
- Prognosis
- Retrospective Study
- Veterinary Medicine
- Veterinary Research
Summary
This research investigates the role of intestial progenitor cells in determining the survival of horses suffering from a serious intestinal injury called large colon volvulus (LCV). The study specifically looks at certain biomarkers (proteins as an indicator of specific cell activity), and their ability to predict the survival of an inflicted animal.
Study Objectives
The research had three main objectives:
- Identify which subpopulations of intestinal progenitor cells are indicated by biomarkers: PCNA, SOX9, PHH3, and Ki-67.
- Establish critical numbers of these biomarker-positive cells that would predict the survival to discharge of LCV cases.
- Examine if survival to discharge is linked to the established cut-off values of these biomarker-positive cells.
Methods
The research was a retrospective cohert study, meaning it looked back at past cases to draw conclusions. The study consisted of adult horses that were admitted to two different hospitals suffering from LCV and underwent a specific surgery (an exploratory coeliotomy). All included horses recovered from general anaesthesia. The researchers performed immunohistochemical analyses (tests to identify particular molecules in cells of a tissue) where they counted cells that tested positively for the targeted biomarkers. Statitical methods were used to determine optimal cut-off values of biomarker-positive cells and to associate these values with the animals’ survival.
Results
The study was conducted on 23 cases of LCV. Among these, 13 horses, or 57%, managed to survive up to discharge. A specific cut-off value of less than 2.1 PHH3 positive cells per crypt (a part of the intestine) could predict death with very high certainty. On the contrary, PCNA, SOX9, and Ki-67 biomarkers did not seem to play a direct role in short-term survival.
Conclusion
Though the population size for the study was small, it suggested that the PHH3 biomarker analysis can aid in more accurate predictions of a horse’s survival chances after suffering from LCV. It is important to remember that while the findings suggest a correlation, the results do not prove causation, and further research may be necessary before this finding can be applied widely.
Cite This Article
Publication
Researcher Affiliations
- Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
- Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
- Peterson and Smith Equine Hospital, Ocala, Florida, USA.
- Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
- Department of Clinical Sciences, North Carolina State University College of Veterinary Medicine, Raleigh, North Carolina, USA.
MeSH Terms
- Animals
- Biomarkers
- Cell Proliferation / physiology
- Cohort Studies
- Colonic Diseases / veterinary
- Female
- Gene Expression Regulation
- Horse Diseases / blood
- Horses
- Intestinal Volvulus / metabolism
- Intestinal Volvulus / pathology
- Intestinal Volvulus / veterinary
- Male
- ROC Curve
- Retrospective Studies
- Survival Analysis
Grant Funding
- K01 OD019911 / NIH HHS
- T35 OD011070 / NIH HHS
References
- Snyder JR, Pascoe JR, Olander HJ, Spier SJ, Meagher DM, Bleifer DR. Strangulation volvulus of the ascending colon in horses.. J. Am. Vet. Med. Assoc. 1989;195:757–764.
- Levi O, Affolter VK, Benak J, Kass PH, Le Jeune SS. Use of pelvic flexure biopsy scores to predict short-term survival after large colon volvulus.. Vet. Surg. 2012;41:582–588.
- Ducharme NG, Hackett RP, Ducharme GR, Long S. Surgical treatment of colic results in 181 horses.. Vet. Surg. 1983;12:206–209.
- Suthers JM, Pinchbeck GL, Proudman CJ, Archer DC. Survival of horses following strangulating large colon volvulus.. Equine Vet. J. 2013;45:219–223.
- Proudman CJ, Edwards GB, Barnes J, French NP. Modelling long-term survival of horses following surgery for large intestinal disease.. Equine Vet. J. 2005;37:366–370.
- Johnston K, Holcombe SJ, Hauptman JG. Plasma lactate as a predictor of colonic viability and survival after 360° volvulus of the ascending colon in horses.. Vet. Surg. 2007;36:563–567.
- Gonzalez LM, Fogel CA, Baker WT, Hughes FE, Law JM, Motsinger-Reif AA, Blikslager AT. Operative factors associated with short-term outcome in horses with large colon volvulus: 47 cases from 2006 to 2013.. Equine Vet. J. 2015;47:279–284.
- van Hoogmoed L, Snyder JR, Pascoe JR, Olander HJ. Use of pelvic flexure biopsies to predict survival after large colon torsion in horses.. Vet. Surg. 2000;29:572–577.
- Gonzalez LM, Kinnin LA, Blikslager AT. Characterization of discrete equine intestinal epithelial cell lineages.. Am. J. Vet. Res. 2015;76:358–366.
- Barker N, van der Wetering M, Clevers H. The intestinal stem cell.. Gene Dev. 2008;22:1856–1864.
- Dekaney CM, Fong JJ, Rigby RJ, Lund PK, Henning SJ, Helmrath MA. Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice.. Am. J. Physiol.-Gastr. L. 2007;293:1013–1022.
- van Hoogmoed L, Snyder JR, Pascoe JR, Olander HJ. Evaluation of uniformity of morphological injury of the large colon following severe colonic torsion.. Equine Vet. J. 2000;32(Suppl. 32):98–100.
- Rowe EL, White NA, Buechner-Maxwell V, Robertson JL, Ward DL. Detection of apoptotic cells in intestines from horses with and without gastrointestinal tract disease.. Am. J. Vet. Res. 2003;64:982–988.
- Malkas LH, Herbert BS, Waleed A, Dobrolecki LE, Liu Y, Agarwal B, Hoelz D, Badve S, Schnaper L, Arnold RJ, Mechref Y, Novoty MV, Loehrer P, Goulet RJ, Hickey RJ. A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker.. PNAS 2006;103:19472–19477.
- Scholzen T, Gerdes J. The ki-67 protein: From the known and the unknown.. J. Cell Physiol. 2000;182:311–322.
- Gonzalez LM, Williamson I, Piedrahita JA, Blikslager AT, Magness ST. Cell lineage identification and stem cell culture in a porcine model for the study of intestinal epithelial regeneration.. PLOS One 2013;8:e66465.
- Roche KC, Gracz AD, Liu XF, Newton V, Akiyama H, Magness ST. SOX9 maintains reserve stem cells and preserves radioresistance in mouse small intestine.. Gastroenterology 2015;149:1553–1563.
- Gerring Z, Pearson JE, Morrin HR, Robinson BA, Harris GC, Walker LC. Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients.. Histopathology 2015;67:538–547.
- Hans F, Demitrov F. Histone H3 phosphorylation and cell division.. Oncogene 2001;20:3021–3027.
- Alkhasawneh A, Reith JD, Toro TZ, Ayed AO, Lu X, George TJ, Duckworth LV. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.. Am. J. Clin. Pathol. 2015;143:385–392.